European heart group issues guidelines on 4 new anticoagulants

05/3/2013 | TheHeart.org (Montreal) (free registration)

The European Heart Rhythm Association of the European Society of Cardiology has released practice guidelines for the use of the oral anticoagulants dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation. The guide includes clinical scenarios and information on managing bleeding risks.

View Full Article in:

TheHeart.org (Montreal) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY